Arctic Bioscience is a biotech company that produces bioactive marine-based pharmaceutical and nutraceutical products and solutions.
Arctic Bioscience has raised $1.5M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in April 2026.
Arctic Bioscience's investors include Tore Tønseth, Runhild Gammelsæter, Jan Endre Vartdal, Christer Valderhaug, Harald Nordal.
Arctic Bioscience is headquartered in Ørsta, Norway.
Arctic Bioscience is a biotech company that produces bioactive marine-based pharmaceutical and nutraceutical products and solutions.
Arctic Bioscience is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arctic Bioscience — Funding & Investors." VCBacked, April 1, 2026, https://www.vcbacked.co/company/arctic-bioscience. Accessed October 7, 2026.
VCBacked. (2026). Arctic Bioscience — Funding & Investors. Retrieved October 7, 2026, from https://www.vcbacked.co/company/arctic-bioscience
{{cite web |title=Arctic Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/arctic-bioscience |website=VCBacked |access-date=October 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated